Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy

Introduction - Autoantibodies against the podocyte protein nephrin were recently identified in a pediatric cohort primarily comprising steroid-sensitive (SSNS) and steroid-dependent (SDNS) nephrotic syndrome (NS). However, their prevalence across all NS subtypes, particularly in steroid-resistant ne...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hengel, Felicitas Eugenia (VerfasserIn) , Dehde, Silke (VerfasserIn) , Yilmaz, Alev (VerfasserIn) , Bayazit, Aysun K. (VerfasserIn) , Ozaltin, Fatih (VerfasserIn) , Paripovic, Dusan (VerfasserIn) , Emma, Francesco (VerfasserIn) , Ronco, Pierre (VerfasserIn) , Vivarelli, Marina (VerfasserIn) , Hogan, Julien (VerfasserIn) , Schaefer, Franz (VerfasserIn) , Tomas, Nicola M. (VerfasserIn) , Huber, Tobias B. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2025
In: Kidney international
Year: 2025, Jahrgang: 107, Heft: 6, Pages: 1099-1103
ISSN:1523-1755
DOI:10.1016/j.kint.2025.01.019
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.kint.2025.01.019
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0085253825000821
Volltext
Verfasserangaben:Felicitas E. Hengel, Silke Dehde, Alev Yilmaz, Aysun K. Bayazit, Fatih Ozaltin, Dusan Paripovic, Francesco Emma, Pierre Ronco, Marina Vivarelli, Julien Hogan, Franz Schaefer, Nicola M. Tomas and Tobias B. Huber, on behalf of the PodoNet Consortium and the International Society of Glomerular Disease

MARC

LEADER 00000naa a2200000 c 4500
001 1936182572
003 DE-627
005 20250918120330.0
007 cr uuu---uuuuu
008 250918s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.kint.2025.01.019  |2 doi 
035 |a (DE-627)1936182572 
035 |a (DE-599)KXP1936182572 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hengel, Felicitas Eugenia  |e VerfasserIn  |0 (DE-588)123427678X  |0 (DE-627)1759163716  |4 aut 
245 1 0 |a Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy  |c Felicitas E. Hengel, Silke Dehde, Alev Yilmaz, Aysun K. Bayazit, Fatih Ozaltin, Dusan Paripovic, Francesco Emma, Pierre Ronco, Marina Vivarelli, Julien Hogan, Franz Schaefer, Nicola M. Tomas and Tobias B. Huber, on behalf of the PodoNet Consortium and the International Society of Glomerular Disease 
264 1 |c June 2025 
300 |b Illustrationen 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 6. Februar 2025, Artikelversion: 20. Mai 2025 
500 |a Gesehen am 18.09.2025 
520 |a Introduction - Autoantibodies against the podocyte protein nephrin were recently identified in a pediatric cohort primarily comprising steroid-sensitive (SSNS) and steroid-dependent (SDNS) nephrotic syndrome (NS). However, their prevalence across all NS subtypes, particularly in steroid-resistant nephrotic syndrome (SRNS), and their relation to therapy response need to be determined to advance pathophysiological understanding and refine treatment strategies. - Methods - A multicenter cohort study measuring anti-nephrin autoantibodies in samples from children with SSNS, SDNS, nongenetic and genetic SRNS was conducted. - Results - Sixty-nine of 101 (68%) patients with SSNS, 19 of 67 (28%) patients with SDNS, 14 of 103 patients (14%) with non-genetic SRNS, and 1 of 62 patients (2%) with genetic SRNS were positive for anti-nephrin autoantibodies. The prevalence of anti-nephrin autoantibodies increased with presence of active disease in cases of SSNS and SDNS. Within the group of non-genetic SRNS patients with active disease, anti-nephrin positivity was found in 13 of 74 (18%) patients responding to intensified immunosuppression compared to none of 17 patients with multidrug-resistant SRNS. - Conclusions - The prevalence of anti-nephrin antibodies is substantially higher in children with steroid responsive NS than in those with SRNS, suggesting that anti-nephrin antibodies primarily drive SSNS/SDNS. In contrast, NS due to podocyte gene mutations is primarily genotype-caused. Anti-nephrin autoantibodies may serve as a positive prognostic marker in pediatric NS, indicating a favorable response to immunosuppressive therapy. 
650 4 |a glomerulonephritis 
650 4 |a nephrin 
650 4 |a podocyte 
650 4 |a steroid-resistant nephrotic syndrome 
700 1 |a Dehde, Silke  |e VerfasserIn  |4 aut 
700 1 |a Yilmaz, Alev  |e VerfasserIn  |4 aut 
700 1 |a Bayazit, Aysun K.  |e VerfasserIn  |4 aut 
700 1 |a Ozaltin, Fatih  |e VerfasserIn  |4 aut 
700 1 |a Paripovic, Dusan  |e VerfasserIn  |4 aut 
700 1 |a Emma, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Ronco, Pierre  |e VerfasserIn  |4 aut 
700 1 |a Vivarelli, Marina  |e VerfasserIn  |4 aut 
700 1 |a Hogan, Julien  |e VerfasserIn  |4 aut 
700 1 |a Schaefer, Franz  |d 1961-  |e VerfasserIn  |0 (DE-588)1023365383  |0 (DE-627)718365577  |0 (DE-576)366705598  |4 aut 
700 1 |a Tomas, Nicola M.  |e VerfasserIn  |4 aut 
700 1 |a Huber, Tobias B.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Kidney international  |d New York, NY : Elsevier, 1972  |g 107(2025), 6 vom: Juni, Seite 1099-1103  |h Online-Ressource  |w (DE-627)32046637X  |w (DE-600)2007940-0  |w (DE-576)091143004  |x 1523-1755  |7 nnas  |a Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy 
773 1 8 |g volume:107  |g year:2025  |g number:6  |g month:06  |g pages:1099-1103  |g extent:5  |a Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy 
856 4 0 |u https://doi.org/10.1016/j.kint.2025.01.019  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0085253825000821  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250918 
993 |a Article 
994 |a 2025 
998 |g 1023365383  |a Schaefer, Franz  |m 1023365383:Schaefer, Franz  |d 910000  |d 910500  |d 50000  |e 910000PS1023365383  |e 910500PS1023365383  |e 50000PS1023365383  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 11 
999 |a KXP-PPN1936182572  |e 4773370068 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","family":"Hengel","display":"Hengel, Felicitas Eugenia","given":"Felicitas Eugenia"},{"given":"Silke","family":"Dehde","role":"aut","display":"Dehde, Silke"},{"given":"Alev","display":"Yilmaz, Alev","family":"Yilmaz","role":"aut"},{"given":"Aysun K.","display":"Bayazit, Aysun K.","role":"aut","family":"Bayazit"},{"display":"Ozaltin, Fatih","family":"Ozaltin","role":"aut","given":"Fatih"},{"display":"Paripovic, Dusan","role":"aut","family":"Paripovic","given":"Dusan"},{"family":"Emma","role":"aut","display":"Emma, Francesco","given":"Francesco"},{"given":"Pierre","role":"aut","family":"Ronco","display":"Ronco, Pierre"},{"display":"Vivarelli, Marina","role":"aut","family":"Vivarelli","given":"Marina"},{"display":"Hogan, Julien","family":"Hogan","role":"aut","given":"Julien"},{"given":"Franz","display":"Schaefer, Franz","family":"Schaefer","role":"aut"},{"role":"aut","family":"Tomas","display":"Tomas, Nicola M.","given":"Nicola M."},{"given":"Tobias B.","display":"Huber, Tobias B.","family":"Huber","role":"aut"}],"language":["eng"],"note":["Online verfügbar: 6. Februar 2025, Artikelversion: 20. Mai 2025","Gesehen am 18.09.2025"],"name":{"displayForm":["Felicitas E. Hengel, Silke Dehde, Alev Yilmaz, Aysun K. Bayazit, Fatih Ozaltin, Dusan Paripovic, Francesco Emma, Pierre Ronco, Marina Vivarelli, Julien Hogan, Franz Schaefer, Nicola M. Tomas and Tobias B. Huber, on behalf of the PodoNet Consortium and the International Society of Glomerular Disease"]},"origin":[{"dateIssuedDisp":"June 2025","dateIssuedKey":"2025"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1936182572"],"doi":["10.1016/j.kint.2025.01.019"]},"recId":"1936182572","title":[{"title_sort":"Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy","title":"Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy"}],"physDesc":[{"extent":"5 S.","noteIll":"Illustrationen"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Kidney international","subtitle":"official journal of the International Society of Nephrology","title_sort":"Kidney international"}],"part":{"text":"107(2025), 6 vom: Juni, Seite 1099-1103","volume":"107","extent":"5","year":"2025","pages":"1099-1103","issue":"6"},"pubHistory":["1.1972 -"],"note":["Gesehen am 20.08.20"],"language":["eng"],"recId":"32046637X","id":{"eki":["32046637X"],"zdb":["2007940-0"],"issn":["1523-1755"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategyKidney international","origin":[{"publisher":"Elsevier ; Blackwell ; Wiley-Blackwell ; Nature Publishing Group","dateIssuedDisp":"1972-","dateIssuedKey":"1972","publisherPlace":"New York, NY ; Oxford [u.a.] ; [Erscheinungsort nicht ermittelbar] ; Basingstoke"}],"corporate":[{"display":"International Society of Nephrology","role":"isb"}]}]} 
SRT |a HENGELFELIANTINEPHRI2025